The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers.
In a spirited conversation, "Shark Tank" star Cuban and Medicare director Chris Klomp discussed the future of health care in the U.S.
Cuban and a top Medicare official touted ways to help consumers save money when purchasing prescription medications.